APP and Alzheimer disease: Chang et al., using a double knock-in mouse model of AD, with mutations both for APP and presenilin-1, showed that AMPA receptors’ EPSPs exhibited an age-related decrease in currents in the presence of an NMDA receptor antagonist [70].